Young-jin Kim's most recent trade in MagnaChip Semiconductor Corp was a trade of 164,269 Performance-Based Restricted Stock Units done . Disclosure was reported to the exchange on June 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2025 | 164,269 | 164,269 | - | - | Performance-Based Restricted Stock Units | |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2025 | 164,269 | 590,970 (1%) | 0% | 0 | Common Stock | |
| 4D Molecular Therapeutics Inc | Robert Young Kim | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 92,300 | 92,300 | - | - | Stock Option (Right to Buy) | |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.02 per share. | 31 Dec 2024 | 17,632 | 635,274 (1%) | 0% | 4.0 | 70,881 | Common Stock |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.02 per share. | 31 Dec 2024 | 15,517 | 619,757 (1%) | 0% | 4.0 | 62,378 | Common Stock |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.02 per share. | 31 Dec 2024 | 5,017 | 652,906 (1%) | 0% | 4.0 | 20,168 | Common Stock |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 267,000 | 267,000 | - | - | Performance-Based Restricted Stock Units | |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 133,000 | 657,923 (1%) | 0% | 0 | Common Stock | |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.61 per share. | 08 Mar 2024 | 17,826 | 524,923 (1%) | 0% | 5.6 | 100,004 | Common Stock |
| 4D Molecular Therapeutics Inc | Young Kim Robert | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 12,000 | 138,000 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Young Robert Kim | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.66 per share. | 05 Feb 2024 | 12,000 | 13,595 | - | 18.7 | 223,920 | Common Stock |
| 4D Molecular Therapeutics Inc | Young Robert Kim | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.05 per share. | 05 Feb 2024 | 12,000 | 1,595 | - | 30.1 | 360,600 | Common Stock |
| 4D Molecular Therapeutics Inc | Young Robert Kim | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.78 per share. | 05 Feb 2024 | 6,000 | 7,595 | - | 15.8 | 94,680 | Common Stock |
| 4D Molecular Therapeutics Inc | Kim Young Robert | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.04 per share. | 05 Feb 2024 | 6,000 | 7,595 | - | 8.0 | 48,240 | Common Stock |
| 4D Molecular Therapeutics Inc | Kim Young Robert | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 6,000 | 64,000 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Young Robert Kim | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 6,000 | 54,000 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Kim Young Robert | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.05 per share. | 05 Feb 2024 | 6,000 | 1,595 | - | 30.1 | 180,300 | Common Stock |
| 4D Molecular Therapeutics Inc | Robert Kim Young | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.05 per share. | 05 Feb 2024 | 6,000 | 1,595 | - | 30.1 | 180,300 | Common Stock |
| 4D Molecular Therapeutics Inc | Kim Young Robert | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.05 per share. | 05 Feb 2024 | 552 | 1,043 | - | 30.1 | 16,588 | Common Stock |
| MagnaChip Semiconductor Corp | Kim Young-Joon | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 31 Dec 2023 | 17,632 | 507,097 (1%) | 0% | 7.5 | 132,240 | Common Stock |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 31 Dec 2023 | 5,017 | 524,729 (1%) | 0% | 7.5 | 37,628 | Common Stock |
| MagnaChip Semiconductor Corp | Kim Young-Joon | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.50 per share. | 31 Dec 2023 | 3,413 | 529,746 (1%) | 0% | 7.5 | 25,598 | Common Stock |
| 4D Molecular Therapeutics Inc | Young Robert Kim | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 8.36 per share. | 14 Aug 2023 | 10,888 | 533,159 (1%) | 0% | 8.4 | 91,024 | Common Stock |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 151,126 | 522,271 (1%) | 0% | 0 | Common Stock | |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.39 per share. | 31 Dec 2022 | 5,304 | 371,145 (1%) | 0% | 9.4 | 49,805 | Common Stock |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.39 per share. | 31 Dec 2022 | 4,010 | 380,057 (1%) | 0% | 9.4 | 37,654 | Common Stock |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.39 per share. | 31 Dec 2022 | 3,608 | 376,449 (1%) | 0% | 9.4 | 33,879 | Common Stock |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 43,000 | 384,067 (1%) | 0% | 0 | Common Stock | |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 17.37 per share. | 24 Feb 2022 | 5,460 | 341,067 (0%) | 0% | 17.4 | 94,840 | Common Stock |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 53,402 | 343,331 (0%) | 0% | 0 | Common Stock | |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.78 per share. | 18 Feb 2022 | 19,759 | 323,572 (0%) | 0% | 18.8 | 371,074 | Common Stock |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 19,104 | 342,676 (0%) | 0% | 0 | Common Stock | |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.78 per share. | 18 Feb 2022 | 7,069 | 335,607 (0%) | 0% | 18.8 | 132,756 | Common Stock |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 29,246 | 297,546 (0%) | 0% | 0 | Common Stock | |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 68,438 | 293,623 (0%) | 0% | 0 | Common Stock | |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.86 per share. | 16 Feb 2021 | 25,323 | 268,300 (0%) | 0% | 19.9 | 502,915 | Common Stock |
| MagnaChip Semiconductor Corp | Young-Joon Kim | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 11.49 per share. | 03 Aug 2020 | 10,000 | 238,148 (0%) | 0% | 11.5 | 114,930 | Common Stock |